The obligately intracellular chlamydiae are bacterial pathogens that occupy intracellular vacuoles, termed inclusions, as they develop and multiply. Typical Chlamydia trachomatis isolates occupy inclusions that fuse with other C. trachomatis inclusions within cells infected with multiple elementary bodies (wild-type phenotype). The authors of this study have recently described C. trachomatis isolates that form multiply-lobed, non-fusogenic inclusions within single cells infected with multiple elementary bodies (variant phenotype). Inclusions formed by these isolates uniformly lacked the protein IncA on the inclusion membrane (IM). In the present work, the study of the C. trachomatis inclusion phenotype has been expanded to include 27 variant and 13 wild-type isolates. Twenty-four of the 27 variant isolates were IncA-negative, as detected by fluorescence microscopy and immunoblotting, but three variants localized IncA to the IM. The IncA-positive variants formed inclusions that fused, at a reduced rate, with those occupied by wild-type isolates and with inclusions formed by other IncA-positive variants. Nucleotide-sequence analysis of the incA sequences from the variant isolates identified a variety of distinct sequence polymorphisms relative to incA from wild-type strains. The authors also demonstrate that a second Inc protein, CT223p, is not found in the IM in selected C. trachomatis isolates. No change in the structure or the fusogenicity of the inclusions was associated with the presence or absence of CT223p.
INTRODUCTION
The chlamydiae are obligate intracellular pathogens that cause a variety of diseases in humans and other animal species. There are at least 15 serovars of Chlamydia trachomatis and naturally occurring variants or subserovars of this species are relatively common (Dean et al., 1991 ; Hayes et al., 1992 ; Lampe et al., 1997 ; Yang et al., 1993) . All chlamydiae develop within a membrane-bound, non-acidified vacuole termed the inclusion 
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derivative from the Golgi apparatus to the inclusion supports a model that places the developing inclusion in the host-cell exocytic vesicular trafficking pathway (Hackstadt et al., , 1996 . The list of chlamydial proteins that are associated with the inclusion membrane (IM) is growing and now includes a candidate protective antigen (Fling et al., 2001) , a component of the type III secretory apparatus (Fields & Hackstadt, 2000) and a collection of chlamydial proteins known as Inc proteins (Bannantine et al., 1998a (Bannantine et al., , 2000 Scidmore-Carlson et al., 1999) . Recently, a host protein (14-3-3β) was shown to localize at the IM through specific interactions with a single Inc protein, IncG (Scidmore & Hackstadt, 2001) . It is likely that similar interactions between chlamydial IM proteins and unidentified host-cell proteins are critical for proper inclusion maturation and productive chlamydial development. 
D. D. Rockey and others
We have recently identified and described a collection of C. trachomatis isolates that form unusual, nonfusogenic inclusions within infected cells (variant phenotype ; Suchland et al., 2000) . This is in contrast to typical C. trachomatis, which occupies inclusions that fuse with other wild-type C. trachomatis inclusions (wild-type phenotype ; Ridderhof & Barnes, 1989) . In this study, we have used immunofluorescence microscopy, immunoblotting and sequence analysis to expand on the characterization of the C. trachomatis isolates occupying the unusual inclusions. In results similar to those that we have reported previously, 24 of the 27 variants lacked IncA on the IM. However, the three remaining variants produced and correctly localized IncA to the IM. The IncA-positive variants formed multiply-lobed, but partially fusogenic, inclusions within cells. A variety of different mutations were found in incA within the variants, which led to truncated predicted proteins in most of the IncA-negative isolates. We also show that an additional Inc protein, C. trachomatis CT223p (encoded by ORF CT223 ; Bannantine et al., 2000) , was variably present in the different isolates but that the presence or absence of CT223p did not correlate with the inclusion structure or its fusogenicity.
METHODS
Chlamydiae. Wild-type chlamydial reference strains of serovar G (G\UW-57) and serovar I (I\UW-12) were described by Wang et al. (1985) . All other isolates were collected and serotyped during the routine evaluation of patients visiting the Seattle and King County Public Health Clinics (Suchland et al., 2000 ; Suchland & Stamm, 1991) . The serovar and laboratory reference number are given for each clinical isolate. All isolates that formed variant inclusions are represented by (s). As reported previously (Suchland et al., 2000) , 1n5-2 % of approximately 11 400 C. trachomatis clinical isolates collected over the course of 12 years showed the variant inclusion phenotype. Twenty-seven variant and 13 wild-type isolates were taken from this collection and used for these analyses (Fig. 1 ).
Antibodies and reagents for microscopy. mAb B9 is directed at a genus-common determinant of the 60 kDa heat-shock protein (HSP60 ; Yuan et al., 1992) . The mAbs GG-11, CC-1 and AC-11 are specific for the C. trachomatis major outermembrane proteins (MOMPs) of serovars G, J and I, respectively (Wang et al., 1985) . The mAb 20F12, produced by the University of Oregon Monoclonal Antibody Facility, is specific for the C. trachomatis Inc protein CT223p (Bannantine et al., 2000) . This antibody was shown, by immunoblotting, to react with both the wild-type and variant CT223p when either protein was produced in E. coli (not shown). Rabbit anti-IncA antisera were produced using described methods (Bannantine et al., 1998b) . These antisera were pre-adsorbed with lysates of uninfected HeLa cells to remove any non-specific background. Mouse mAb 3H7 (IgG " ), directed at C. trachomatis IncA, was produced using a C. trachomatis IncA-maltose-binding protein fusion as the immunogen. The specificity of the antisera was determined by immunoblotting and fluorescence microscopy. Secondary antibodies were purchased from the Pierce Chemical Co. DNA was labelled with 4h,6-diamidino-2-phenylindole dihydrochloride (DAPI), which was added at 2 µg ml − " to the mounting medium.
Chlamydial culture and immunofluorescence. The non-fusing chlamydial phenotype was identified visually, by observing the inclusion morphology during large-scale serotyping studies in a low-passage microtitre-plate format (Suchland & Stamm, 1991) . Chlamydia-infected cells were detected by fluorescence microscopy using mAb CF-2, which was directed at the genuscommon lipopolysaccharide determinant of Chlamydia spp. (Washington Research Foundation, Seattle, WA).
Examination of the fusogenicity of inclusions was conducted via the analysis of mixed infections in HeLa-cell monolayers, using the strains indicated in the legends to Figs 2, 3 and 5. For the mixed infections, one isolate was inoculated onto cells in SPG (0n25 M sucrose, 10 mM sodium phosphate, 5 mM -glutamic acid, pH 7n2) and incubated for 1 h at room temperature on a rocking platform. The inocula were removed and the cells were washed twice with Hank's Balanced Salts Solution (Life Technologies). The cells were then incubated for 1 h at 37 mC in Minimal Essential Medium plus 10 % fetal calf serum (MEM-10 ; Life Technologies), prior to their inoculation with a second chlamydial isolate. Cells were again incubated for 1 h at room temperature prior to the removal of the inocula, the addition of the medium and incubation at 37 mC in 5% CO # . These sequential infections were used to reduce the likelihood of two different chlamydial elementary bodies entering the same vacuole. Cells were then cultured for 30 h prior to being fixed in methanol and prepared for fluorescence microscopy. Monolayers were stained as described previously (Rockey & Rosquist, 1994) . Fluorescence images were visualized under a Leica DMLB microscope by using the 100i objective and collected digitally with a SPOT camera (Diagnostic Instruments). Images were processed by using Photoshop 6.0 (Adobe Software) and Canvas 5.03 (Deneba Software).
Electrophoresis and immunoblotting. Protein electrophoresis was conducted as described previously (Rockey & Rosquist, 1994) . Briefly, C.-trachomatis-infected HeLa cells that had been cultured in 6-well trays were lysed with ice-cold electrophoresis sample buffer (Rockey & Rosquist, 1994) and boiled for 2 min. Samples were then aliquoted and stored at k20 mC. Chlamydial lysates were standardized for electrophoresis using the relative level of chlamydial HSP60. Rabbit antibodies were detected with $&S-labelled staphylococcal protein A [37 kBq ml − " (1 µCi ml − ") ; Amersham] followed by autoradiography. Mouse antibodies were detected using peroxidase-conjugated chicken-anti-mouse IgG (ECL reagents), followed by chemiluminescent detection.
DNA amplification and sequence analysis of incA and CT223.
Analysis of the incA sequences from the 39 clinical isolates discussed in this work was performed (Fig. 1) . Sequence analysis was conducted on the CT223 sequences from a total of 12 isolates ; this included several serovars and isolates with both the variant and wild-type inclusion morphologies.
Amplification products for sequencing were prepared and processed using the following techniques. 
Fig. 1.
Sequence analysis of the chlamydial isolates examined in this study. For each isolate, the strain designation is indicated in the left column and the accession number for the incA sequence is indicated in the right column. The complete incA sequence was determined for the isolates shown in bold, whereas the first 450-500 nt were analysed for all other isolates. The sequences of incA from five additional wild-type isolates (E9332, J2364, J3464, J9311 and J9325) were identical to that of the serovar D sequence in the Chlamydia genome-project database (Stephens et al., 1998) , and these sequences are not represented in the figure centrifuged. Five microlitres of this sample were used as the template for the amplification of target sequences. All amplification products were generated by using Taq DNA polymerase (Life Technologies) in 100 µl reactions. Two independent incA amplification products were produced for sequence analysis. The first product, produced by using oligonucleotides CT30 (5h-AGCCATAGGATCTGGTTTC-AGCGA-3h) and CT31 (5h-GCGCGGATCCTAGGAGCTT-TTTGTAGAGGGTGA-3h) as primers, amplified the complete coding sequence of incA plus 45 upstream nucleotides. The second product, produced by using oligonucleotides JB193 (5h-GTTTTTTCATGGCCTCTTCTCT-3h) and CT33 (5h-GATCTGCTATGATTTCTTGCG-3h) as primers, included approximately two-thirds of incA and 429 upstream nucleotides. These two amplification products overlapped through the first 532 nt of the incA coding sequence. Products from these amplifications were purified using Qiaquick columns (Qiagen). The overlapping region of each amplification product was sequenced, yielding two independent nucleotide sequences for comparison. The entire incA ORF was sequenced in cases where the incA reading frame was not altered in the first 450 nt. Full-length incA was cloned into the pCR2.1 vector (Invitrogen) and the nucleotide sequence was determined using oligonucleotides from within incA and primers specific to vector sequences. Similar procedures were used for the amplification and sequence analysis of CT223, using oligonucleotides 35-1 (5h-ATGGTGAGTTTAGCAT-TAGGGA-3h) and 35-2 (5h-GCGCGGATCCTACACCCGA-GAGCCGTAATTGAA-3h) as primers.
All nucleotide sequencing was conducted at the Central Services Laboratory of the Oregon State University Center for Gene Research and Biotechnology using a model 373A or a model 377 automated DNA sequencer (both Applied Biosystems). Sequence editing and analysis was performed with MacVector 6.0 and Assemblylign 1.07 (Oxford Molecular Group, Campbell, CA).
RESULTS
In Fig. 1 number is provided for each isolate (Fig. 1) . The following sections provide details about the isolates examined in this study.
Fluorescence microscopy and immunoblotting of cells infected with different variants
Wild-type isolates of C. trachomatis form single inclusions following the infection of HeLa cells at high multiplicities ( Fig. 2A, D) . The localization of IncA to the IM has been demonstrated in over 50 fusogenic wildtype clinical isolates (Fig. 1, and data not shown) . In contrast, multiple, or lobed, inclusions form in HeLa cells infected under similar conditions by variant C. trachomatis isolates (Fig. 2B, E) . Two distinct groups of the variant isolates were identified with respect to the presence or absence of IncA in the IM. Twenty-four of the 27 variant isolates lacked IncA on the IM [isolates J(s)893 (Fig. 3C, D ) and J(s)1980 (Fig. 3E, F) ]. Tracelabelling of the developmental forms of C. trachomatis with the anti-IncA antisera can occasionally be observed in some images (Fig. 3C ). This background labelling was never seen at the IM. The remaining three variants occupied multiply-lobed inclusions that were IncApositive [for example, G(s)459 (Fig. 2B , E, C, F) and J(s)5942 (Fig. 3A, B) ]. The IncA-negative variant isolates were found in each oculogenital serovar, whereas the three IncA-positive variants were of serovars J(s) and G(s) (Fig. 1) .
The examination of the Inc protein CT223p was initially included as a positive control for IM staining of the IncA-deficient strains. In the course of these studies, however, several isolates were identified that did not accumulate CT223p in the IM (represented in Fig. 3F) . One of the 13 wild-type isolates (J9325) and three of the 27 variants [J(s)6276, J(s)6686 and J(s)1980] were shown to lack CT223p, as measured by immunofluorescence. All of the identified CT223p-negative isolates belonged to serovar J or J(s). There was no correlation between fusogenicity and non-fusogenicity, or any other observable aspect of inclusion development, and the presence or absence of CT223p.
Immunoblotting of infected-cell lysates was used to confirm the antigenic profiles identified by immunofluorescence, and to demonstrate that the IncA-negative or CT223p-negative chlamydiae not only failed to localize IncA and CT223p to the IM, but that they also failed to accumulate detectable levels of either protein within the infected cells (Fig. 4) . Chlamydial HSP60 was included as a control, to demonstrate that similar amounts of total chlamydial antigen were loaded for each sample. Also included in these immunoblots were lysates of J (s) ( Fig. 1 ) and in previous work (Suchland et al., 2000) to encode an apparently intact polypeptide. In these and all other tested isolates, the results from the immunoblotting confirmed the results from the immunofluorescence. In all cases, isolates that lacked detectable IncA or CT223p in the IM were also negative for these proteins upon immunoblotting.
Characterization of the inclusion occupied by the IncA-positive variants
The three IncA-positive isolates (Figs 2B, C, E, F and 3A, B) that form multiply-lobed, apparently nonfusogenic inclusions at a high m.o.i. represent a new class of variant isolate that is distinctly different from the IncA-negative, non-fusogenic variant class. The IncA-positive variants were contrasted with the IncAnegative group to examine why these isolates formed multiply-lobed inclusions. First, limiting-dilution experiments were performed to determine if the number of inclusions per cell was a function of the initial number of elementary bodies that contacted the cell. In cells infected at an m.o.i. much less than 1, cells infected with the IncA-positive variants nearly uniformly contained single inclusions (Fig. 2C, F) . Therefore, as is seen with the IncA-negative variants (Suchland et al., 2000) , the number of vacuoles per cell varied directly with the m.o.i. Mixed-infection experiments were conducted to examine whether the IncA-positive variant isolates formed vacuoles with any ability to fuse with other C. trachomatis inclusions. Studies were undertaken to determine if the inclusions fused with those occupied by either IncA-positive or IncA-negative variants, or with those occupied by wild-type strains. To determine if the IncA-positive variants occupied inclusions that fused with wild-type inclusions, monolayers of HeLa cells were serially infected with C. trachomatis I\UW-12, a wild-type strain, followed by infection with an IncApositive serovar J variant [isolate J(s)9045]. Chlamydial growth and inclusion development were then monitored with mAbs specific for the MOMP of each serovar. Fluorescence-microscopy analysis of cells infected with I\UW-12 and J(s)9045 demonstrated that both serovars were commonly found within the same vacuole (Fig.  5A ). This is in contrast to the results from mixed infections with two IncA-negative non-fusogenic strains, which were never found in the same vacuoles as the wild-type in similar experiments (Suchland et al., 2000) . These data indicate that, in contrast to the IncA-negative non-fusogenic isolates, the IncA-positive variants occupy vacuoles that can fuse with inclusions formed by wild-type C. trachomatis.
Next, we examined whether IncA-positive variants occupied inclusions that could fuse with one another or with inclusions formed by IncA-negative isolates. For these analyses, an IncA-positive G(s) variant was used in serial infections with either an IncA-negative or an IncApositive J(s) variant. These experiments were complicated by the unavailability of subisotypically distinct serovar-specific anti-MOMP mAbs for the double-label fluorescence microscopy of chlamydiae belonging to serovars J and G. Hence, infected cells were labelled with mAb 20F12, which labels CT223p in the IM of inclusions formed by each isolate (shown red in Fig. 5B , C), and with mAb GG-11, which is specific for the MOMP of serovar G (shown green in Fig. 5B, C) . The images in Fig. 5 (B, C) represent cells that were coinfected with G(s)459 and either IncA-negative J(s)893 (Fig. 5B) or IncA-positive J(s)9045 (Fig. 5C ). As shown in Fig. 5(A) , each of the multiple inclusions in these cells was fully laden with chlamydial developmental forms.
Because no antibody specific for the MOMP of serovar J was used, inclusions containing only serovar J(s) developmental forms appeared as empty vacuoles, inclusions containing only serovar G(s) developmental forms appeared as dense green vacuoles and fused inclusions, containing both isolates, appeared as spotted green vacuoles. No fused vacuoles were evident in cells infected with both an IncA-negative variant and an IncA-positive variant (Fig. 5B) . However, examples of both fused and non-fused inclusions were common in monolayers infected with two IncA-positive variants (Fig. 5C) . Collectively, these experiments demonstrated that the IncA-positive variants formed inclusions that retained some fusogenicity and that these vacuoles can fuse with inclusions formed by wild-type isolates and those formed by other IncA-positive variants.
Analysis of the incA sequences from the wild-type and variant clinical isolates
The nature of the lesion leading to the lack of IncA seen in the non-fusogenic variants was addressed by using nucleotide sequencing. Amplification products of incA from a total of 26 independent variant isolates and 13 wild-type strains were subjected to sequence analysis (Fig. 1) . A wide variety of distinct sequences were identified in the variant isolates that lacked IncA. Singlenucleotide frameshifts were found within incA of 12 variants, which led to prematurely terminated protein sequences. In seven of the variants, single base changes led directly to translational stops. Larger deletions were identified in three of the variants. A single isolate, J(s)6686, had a 14 nt deletion that altered the reading frame and led to a very short truncated predicted aminoacid sequence. Two J(s) isolates, J(s)6462 and J(s)893, had identical 51 nt in-frame deletions that encoded an internally deleted polypeptide sequence. A 671 nt deletion was identified in isolate H(s)5642 that included the 3h-terminal 457 nt of incA and extended into the 3h-untranslated region. The complete incA sequence was also determined for two of the three IncA-positive variants, G(s)459 and J(s)5942 (Fig. 1) . The incA gene of both of these variants encoded intact, full-length proteins that had no unique changes relative to either the IncA-negative variants or the wild-type isolates.
In a previous report (Suchland et al., 2000) we identified three nucleotide changes that led to two amino-acid changes in a single non-fusogenic isolate, D(s)2923. The analysis presented in Fig. 1 demonstrates that the changes found in the incA sequence of this isolate are also found in the incA sequences of several additional variants and in the incA sequences from three of the 13 wild-type strains. Therefore, these changes are not unique to the non-fusogenic isolates. These conclusions are consistent with the results of Pannekoek et al. (2001) , who also demonstrated that these mutations are not unique to the incA sequences of the non-fusers. An analysis was also done on the 400 nt sequence upstream of the start codon of the incA gene of isolate D(s)2923. This was conducted to determine whether changes in the promoter sequence might be responsible for the lack of IncA seen in this strain -D(s)2923 has an intact coding sequence. Surprisingly, the sequence of the region upstream of incA in this isolate was identical to that found in the genomic sequence of serovar D (Stephens et al., 1998 , and GenBank accession no. AF163773). The complete gene sequence was determined for eight independent CT223 ORFs, including three serovar J or J(s) isolates that were CT223p-negative, as determined by fluorescence microscopy and immunoblotting, and five isolates that localized CT223p to the IM. The predicted CT223p amino-acid sequences for serovars L2 and D are 91 % identical. Each of the CT223p-positive isolates encoded a protein that was identical either to the serovar D sequence or to a protein that was a mosaic of the CT223p sequences of serovars D and L2. Each of the three CT223p-negative isolates encoded an identical predicted protein sequence, but these sequences had two D. D. Rockey and others changes that were not found in any of the CT223p-positive isolates [Leu for Ser at position 22, Arg for Glu at position 120 ; see accession nos AF279363, AF279362 and AF279364 for J3464, J(s)1980 and J(s)6686, respectively].
DISCUSSION
In a previous study we identified clinical isolates that formed multiple inclusions in cells infected at a high m.o.i. (Suchland et al., 2000) . This is in contrast to wildtype C. trachomatis isolates that form inclusions that fuse in cells infected at an m.o.i. 1. In that study, three non-fusogenic C. trachomatis isolates were examined ; each lacked detectable IncA on the IM. This led us to propose that IncA was associated with the fusogenic nature of the chlamydial inclusion, a concept that was supported by the micro-injection and twohybrid studies conducted by Hackstadt et al. (1999) . We continued to examine the culture collection used in our previous study (Suchland et al., 2000) for variants, and in doing so have identified a phenotypically distinct collection of variant isolates. A detailed examination of a total of 27 variant isolates led to the identification of three independent IncA-positive isolates that occupy multiply-lobed, apparently non-fusogenic inclusions following infection at high multiplicities. The IncApositive variant inclusions were similar to the inclusions formed by the IncA-negative variants, but the size and shape of the former were more irregular (Fig. 2B, E) . Mixed-infection studies subsequently demonstrated that the inclusions formed by the IncA-positive variant isolates can fuse with wild-type inclusions and with inclusions formed by other IncA-positive strains (Fig. 5) . Similar mixed-infection studies did not, however, identify any examples where inclusions formed by IncApositive chlamydiae fused with IncA-negative inclusions. These data support the conclusion that IncA is important in the homotypic fusion of C. trachomatis inclusions. The data expand on this concept to demonstrate that in some isolates additional, yet unidentified, factors also play a role in the efficiency or rate of fusion of C. trachomatis inclusions. Initially, CT223p was included in this study as a positive control for the localization of the IM in the fluorescencemicroscopy detection of the IncA-negative inclusions. Screening of our isolate collection, however, identified four isolates that did not localize detectable amounts of CT223p to the IM. Three CT223p-negative isolates were non-fusogenic and one was wild-type with respect to fusogenicity. Therefore, the absence of CT223p was not correlated with the non-fusogenic phenotype. Our ability to randomly identify the isolates that lacked CT223p suggests that these variants may be common. As several different Inc proteins are produced by different chlamydiae (Bannantine et al., 1998a (Bannantine et al., , b, 2000 Rockey et al., 1995 ; Scidmore-Carlson et al., 1999) , it is possible that variation similar to that seen for IncA and CT223p is common among other Inc proteins and that this may be a means of modulating other, unknown, phenotypes.
The sequence analyses performed in this study demonstrated considerable diversity within the incA sequences from the non-fusogenic clinical C. trachomatis isolates. Several different types of sequence changes were identified, including base exchanges that directly introduced stop codons, single base frameshifts and larger deletions. In most cases (i.e. for 21 of the 24 IncA-negative isolates), the absence of IncA was associated with the interruption of the proper reading frame. In the remaining three isolates, however, the reasons for the absence of detectable IncA remain unclear. The incA sequence of the original IncA-deficient isolate, D(s)2923, has 3 nt changes that were also found in three of 13 wild-type strains, and in wild-type sequences identified by Pannekoek et al. (2001) . Two IncA-negative J(s) isolates were analysed whose incA sequences each had a 51 nt, in-frame deletion that encoded a predicted protein that lacked 17 aa. One possibility for the lack of IncA in the isolates that encode apparently intact polypeptides is that differences in the promoter sequence lead to the production of truncated IncA. This idea was examined by performing an analysis on the incA sequence of isolate D(s)2923. Analysis of the 400 nt upstream of incA in this isolate showed that this region was identical to that in the serovar D genomic sequence. Therefore, the mechanism used by these strains to block the synthesis or the accumulation of IncA remains an open question and is a major focus of research in our laboratory. We are currently examining the transcription and possible translation of incA in these unusual isolates. The identification of the variant chlamydial isolates has allowed us to perform a focused examination of genetic variation within the chlamydiae and to associate this variation with a phenotype. While much of the biology associated with variations in IncA or CT223p remains to be elucidated, there is evidence that differences in clinical presentation following infection by C. trachomatis may be associated with differences in the inclusion phenotype of the infecting chlamydiae. Geisler et al. (2001) used a retrospective case-control analysis to demonstrate that infection with non-fusogenic variants is associated with less severe clinical signs of infection, and lower numbers of recoverable chlamydiae, than infection with wildtype strains. The relatively high percentage of nonfusogenic isolates (1n5 % of approximately 11 400 isolates ; Suchland et al., 2000) supports the possibility that the non-fusogenic phenotype offers a selective advantage to the variant strains, perhaps by increasing their opportunity for cryptic infection. We anticipate that a continued analysis of these variants will, in many ways, add to our basic understanding of the mechanisms used by chlamydiae for their growth and development within infected host cells and to our understanding of the mechanisms used by chlamydiae to cause disease.
